Edition:
India

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

10,638.00ZAc
4:32pm IST
Change (% chg)

-101.00 (-0.94%)
Prev Close
10,739.00
Open
10,799.00
Day's High
10,800.00
Day's Low
10,600.00
Volume
393,546
Avg. Vol
1,676,527
52-wk High
29,800.00
52-wk Low
6,899.00

Summary

Name Age Since Current Position

Kuseni Dlamini

50 2017 Non-Executive Chairman of the Board

Stephen Saad

54 2014 Group Chief Executive, Executive Director

Michael Attridge

57 Deputy Group Chief Executive, Executive Director

Riaan Verster

42 2013 Company Secretary and Group Governance Officer

Roy Andersen

70 2010 Lead Independent Non-Executive Director

Christopher Mortimer

57 1999 Non-Executive Director

David Redfern

52 2015 Non-Executive Director

Linda de Beer

49 2018 Non-Executive Independent Director

Ben Kruger

2019 Non-Executive Independent Director

Themba Mkhwanazi

47 2019 Non-Executive Independent Director

Babalwa Ngonyama

44 2016 Non-Executive Independent Director

Sindiswa Zilwa

52 2006 Non-Executive Independent Director

Biographies

Name Description

Kuseni Dlamini

Mr. Kuseni Douglas Dlamini is an Independent Non-Executive Chairman of the Board of Aspen Pharmacare Holdings Limited. with effect from 7 December 2015. He holds MPhil (Oxon); BSocSci (Hons), (Natal). Kuseni is a graduate of the University of Natal, Durban, and Oxford where he was a Rhodes Scholar. Kuseni was previously Chief Executive Officer of Old Mutual South Africa and Emerging Markets. He brings a wealth of economic and business skills to the Board having previously held positions as the Head of Anglo American South Africa and Executive Chairman of Richards Bay Coal Terminal Company. Kuseni currently serves as Chairman of the South African National Parks (SANParks). He is a former member of the Global Agenda Council on Economic Growth and Poverty Alleviation formed by the World Economic Forum. He is active in academic and professional bodies which include the Council of the University of Pretoria, South African Institute of International Affairs (SAIIA) and the advisory boards of the Wits Business School and Common Purpose.

Stephen Saad

Mr. Stephen Bradley Saad, CA(SA), is a Group Chief Executive, Executive Director of Aspen Pharmacare Holdings Ltd.Executive director Stephen is a founding shareholder of the Aspen Group and his responsibilities extend to include development of strategy and global transactions, geographic expansion and product diversification of Aspen in developed and emerging markets as a leading multinational pharmaceutical company

Michael Attridge

Mr. Michael Guy Attridge, CA(SA), is a Deputy Group Chief Executive, Executive Director of Aspen Pharmacare Holdings Ltd. Executive director A founder of Aspen, Gus is the Deputy Group Chief Executive of the Aspen Group. He is also a member of the Social & Ethics Committee and attends meetings of all of the other Board Committees by invitation. In addition to his other responsibilities, Gus also performs the duties of the Company’s Financial Director.

Riaan Verster

Mr. Riaan Verster is a Company Secretary and Group Governance Officer of Aspen Pharmacare Holdings Ltd. Riaan is an admitted attorney, having qualied as such in 2000. He has practiced as a company secretary for almost 10 years, rst as the Group Company Secretary at Bell Equipment Limited and currently as the Company Secretary & Group Governance Ofcer of Aspen Pharmacare, a position he has held since September 2011

Roy Andersen

Mr. Roy Cecil Andersen, CA(SA), CPA (Texas), is no longer Lead Independent Non-Executive Director of Aspen Pharmacare Holdings Limited., effective September 30 2019. He is a Chartered Accountant by profession and with significant experience in the banking, insurance, construction and packaging industries, Roy’s expertise in fields such as governance and remuneration have been of great benefit to Aspen. He was previously Chairman and Chief Executive of Ernst & Young, Chief Executive of the Liberty Group Limited and a former President of JSE Limited. Roy is currently a non-executive director of Nampak Limited, Chairman of SASFIN Limited and SASFIN Bank Limited and a Major General in the South African National Defence Force, holding the post of Chief of Defence Reserves. He is a member of the King Committee on Corporate Governance. Roy serves as lead independent non-executive director and is the Chairman of the Remuneration & Nomination Committee and a member of the Audit & Risk Committee.

Christopher Mortimer

Mr. Christopher Nattle Mortimer, BA, LLB, is a Non-Executive Director of Aspen Pharmacare Holdings Ltd., since January 1999. He has been a full-time practising attorney since 1988 and has substantial legal and commercial expertise. His intimate knowledge of the Group, its business operations and governance processes has been of immense benefit to Aspen over the years and he continues to serve the Board as a trusted adviser. As Chris’ firm is intermittently called upon to provide legal advice to the Group, he is classified as a non-independent executive director.

David Redfern

Mr. David Redfern is a Non-Executive Director of the Company. David was appointed chief strategy officer of GSK in May 2008 and is responsible for corporate development and strategic planning. He has, in this role, assisted GSK in numerous bolt-on acquisitions and joint ventures including, in particular, a multi-billion dollar threeway asset swap with Novartis. He is a member of GSK’s Corporate Executive Team and reports to the CEO. Prior to holding this position, he was responsible for the leadership of GSK’s business in Northern Europe from 2005 to 2008 and Central and Eastern Europe from 2002 to 2005. He joined Glaxo in 1994 in finance and progressed through a series of finance roles before becoming Finance Director of the European business in 1999. In addition to his current role, David is Chairman of ViiV Healthcare Limited. ViiV is a joint venture between GSK, Pfizer and Shionogi and focuses specifically on the development and commercialisation of medicines to treat HIV.

Linda de Beer

Ms. Linda de Beer has been appointed as an Non-Executive Independent Director of the Company, effective July 31, 2018. Linda serves as an independent nonexecutive director on a number of JSElisted boards, namely Sasfin Holdings Limited (including Sasfin Bank Limited) and Omnia Holdings Limited. She chairs the audit committees of these boards and also serves on a number of their other board committees. In addition, she advises corporates in South Africa and Namibia on reporting, auditing and corporate governance. She is a member of the Investor Advisory Group of the Public Company Accounting Oversight Board (“PCAOB”) in the United States of America, a member of the King Committee, the chair of the Financial Reporting Investigation Panel of the JSE and an Honorary Professor, on a part time basis, at the University of Johannesburg. Linda is a member of the Audit & Risk and Remuneration & Nomination Committees.

Ben Kruger

Mr. Ben Kruger is appointed as Non-Executive Independent Director of the Company, effective April 1, 2019. Ben joined Standard Corporate and Merchant Bank in 1985 and, after having fulfilled various leadership roles in corporate and investment banking, was appointed as Chief Executive in 2001. In March 2013, Ben was appointed as Co-Chief Executive Officer of the Standard Bank Group Limited, a position he retired from on 31 December 2018. He currently serves as a non- executive director on the board of ICBC Standard Bank Plc and Stanbic IBTC Holdings Plc and as an independent non-executive director on the board of JSE Limited. He is a member of the Institute of Directors of Southern Africa and served on the board of the International Institute of Finance. Ben is a Chartered Accountant (SA) and has completed the Advanced Programme in Management at Harvard Business School.

Themba Mkhwanazi

Mr. Themba Mkhwanazi is appointed as Non-Executive Independent Director of the Company, effective April 1, 2019. Themba was appointed as the Chief Executive Officer of Kumba Iron Ore Limited, a member of the Anglo American Plc Group, in September 2016. Prior to this appointment, he held several senior executive positions at various companies, including: Anglo American Coal South Africa (Chief Executive Officer), Rio Tinto Technology and Innovation (Regional General Manager – Americas), Rio Tinto Australia (General Manager – Expansion Support), Richards Bay Minerals (Chief Operating Officer) and Huntsman Tioxide Southern Africa (Managing Director). Themba holds a B.Eng (Hons) in Chemical Engineering from the University of Teesside, Middlesbrough (UK).

Babalwa Ngonyama

Ms. Babalwa Ngonyama serves as Non-Executive Independent Director of the CompanyBabalwa is the CEO of Sinayo Securities (Pty) Limited, a women-owned and managed securities rm, and the deputy chairperson of Brand South Africa. Prior to this, she held positions as the Group Chief Internal Auditor of Nedbank Limited, Chief Financial Ofcer of Saka Holdings (Pty) Limited, partner at Deloitte (Financial Institutions Services Team and chairperson of the Transformation Advisory Board), and audit partner at Nkonki Incorporated. She is, amongst others, a non-executive director and member of the audit committees of The Hollard Insurance Company Limited, Impala Platinum Holdings Limited, and therefore brings considerable nancial and commercial experience to the Board. Babalwa is also a non-executive director and chairperson of the audit committee of Clover Industries Limited. Babalwa is the founding chairman of the African Women Chartered Accountants (AWCA), and currently a member of its Advisory Board. Babalwa is the chairman of the Audit & Risk Committee.

Sindiswa Zilwa

Ms. Sindiswa Victoria Zilwa is a Non-Executive Independent Director of Aspen Pharmacare Holdings Ltd., Sindi is the co-founder and retired Chief Executive Ofcer of Nkonki Incorporated, having held the position from 1998 to 2016. A Chartered Accountant by profession, Sindi is an expert in the areas of accounting, auditing and business management. Sindi is also a Chartered Director (SA) and has vast experience as a director in the public and private sectors, currently serving as a non-executive director of Discovery Holdings Limited, Metrole Limited, Mercedes-Benz South Africa Limited, Tourvest Group (Pty) Limited and Gijima Limited, among others. She is an author of “The ACE Model-Winning Formula for Audit Committees”, used by the Institute of Directors to train audit committee members in South Africa, and the author of “Creating Board and Committee Effectiveness”. She is a member of the South African Institute of Chartered Accountants and Independent Regulatory Board for Auditors. Sindi was previously non-executive Chairman of Airports Company South Africa and a nonexecutive director of Woolworths Limited, Primedia Limited, Wiphold Limited, Ethos Private Equity, Institute of Directors, Alexkor Limited, Rebosis Limited, ATNS SOC Limited, AngloGold Ashanti Limited and previously chaired the BUSA Standing Committee on Transformation.

Basic Compensation

Name Fiscal Year Total

Kuseni Dlamini

1,098,000

Stephen Saad

17,154,000

Michael Attridge

14,108,000

Riaan Verster

--

Roy Andersen

664,000

Christopher Mortimer

345,000

David Redfern

284,000

Linda de Beer

45,000

Ben Kruger

--

Themba Mkhwanazi

--

Babalwa Ngonyama

622,000

Sindiswa Zilwa

701,000
As Of  30 Jun 2018